Reporter Aug 7 2015
Origins of neuroblastoma
Aug. 12, 2015—Vanderbilt researchers are exploring how neuroblastoma tumors begin and progress, knowledge that could provide new treatments for this pediatric cancer.
Drug combos enhance ovarian cancer cell death
Aug. 11, 2015—Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities.
Bridging the antibiotic gap
Aug. 7, 2015—Vanderbilt researchers have discovered how certain molecules with antibiotic properties are synthesized, findings that could lead to new drugs that overcome the increased antibiotic resistance in bacteria.
Stomach cancer cues
Aug. 6, 2015—Vanderbilt scientists have discovered a new molecular mechanism that promotes stomach cancer development, findings that could provide new opportunities for treatment.
Genotyping project to be an ‘engine of discovery’
Aug. 6, 2015—Vanderbilt University researchers next month will launch a major initiative to acquire “dense genotypes” from 100,000 individuals whose medical histories are known.
Rothman named to lead population health research efforts
Aug. 6, 2015—Russell Rothman, M.D., MPP, professor of Medicine, Pediatrics and Health Policy, chief of the Section of Internal Medicine and Pediatrics and director of the Vanderbilt Center for Health Services Research, has been named assistant vice chancellor for Population Health Research.
New targeted therapy shows promise for rare joint tumor
Aug. 6, 2015—Vanderbilt-Ingram Cancer Center (VICC) investigators and colleagues at several major medical centers have been testing a new targeted therapy that is showing promise for the treatment of a rare tumor that forms in and around joint cavities.
Skaar receives American Asthma Foundation award
Aug. 6, 2015—Eric Skaar, Ph.D., MPH, the Ernest W. Goodpasture Professor of Pathology, has received a Scholar Award from the American Asthma Foundation (AAF).
Study tracks postural orthostatic tachycardia syndrome
Aug. 6, 2015—Vanderbilt University Medical Center (VUMC) and Dysautonomia International are partnering to launch the first large international study on postural orthostatic tachycardia syndrome (POTS), which impacts an estimated 500,000 to 3 million patients in the United States and millions more around the globe.
Damon to lead Chemical and Physical Biology grad program
Aug. 6, 2015—Bruce Damon, Ph.D., has been named director of Vanderbilt University’s Chemical and Physical Biology (CPB) graduate program, which prepares students for “cutting-edge” research careers at the interface of the chemical sciences, physical sciences and biology.
Sanders named interim editor of prominent journal
Aug. 6, 2015—Pioneering Vanderbilt University structural biologist Charles Sanders, Ph.D., has been named interim editor of Biochemistry, an eminent journal for publishing research articles about the molecular structure, mechanisms and interactions of important biological molecules.
Vanderbilt Clinical Trials Radiology Support Core launched
Aug. 6, 2015—Vanderbilt’s Department of Radiology and Radiological Sciences has launched the Vanderbilt Clinical Trials Radiology Support Core.